583 related articles for article (PubMed ID: 10581328)
1. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
[No Abstract] [Full Text] [Related]
2. Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humans.
Port RE
Int J Clin Pharmacol Ther; 1997 Feb; 35(2):78-9. PubMed ID: 9147714
[No Abstract] [Full Text] [Related]
3. Drug delivery in cancer using liposomes.
Dass CR
Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
5. Liposomes and cancer therapy.
Gregoriadis G; Florence AT
Cancer Cells; 1991 Apr; 3(4):144-6. PubMed ID: 1883687
[No Abstract] [Full Text] [Related]
6. [Influence of the diameter of the drug carriers for accumulation to tumors].
Murota H; Goto A; Unno K
Nihon Rinsho; 1989 Jun; 47(6):1363-8. PubMed ID: 2769997
[No Abstract] [Full Text] [Related]
7. Liposomes designed to avoid the reticuloendothelial system.
Papahadjopoulos D; Gabizon A
Prog Clin Biol Res; 1990; 343():85-93. PubMed ID: 2198586
[TBL] [Abstract][Full Text] [Related]
8. Characterization and pharmacokinetics of a novel pirarubicin liposome powder.
Cong W; Liu Q; Chen X; Gao R; Lu J; Wang Y; Luo G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1186-94. PubMed ID: 20515395
[TBL] [Abstract][Full Text] [Related]
9. Liposomes for drug delivery to mitochondria.
Boddapati SV; D'Souza GG; Weissig V
Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of high molecular weight agents.
Cassidy J; Newell DR; Wedge SR; Cummings J
Cancer Surv; 1993; 17():315-41. PubMed ID: 8137346
[TBL] [Abstract][Full Text] [Related]
11. Development and use of ceramide nanoliposomes in cancer.
Watters RJ; Kester M; Tran MA; Loughran TP; Liu X
Methods Enzymol; 2012; 508():89-108. PubMed ID: 22449922
[TBL] [Abstract][Full Text] [Related]
12. Physical mechanisms and methods employed in drug delivery to tumors.
Besić E
Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
[TBL] [Abstract][Full Text] [Related]
13. [Segidrin: a new-type antineoplastic agent].
Filov VA
Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
[No Abstract] [Full Text] [Related]
14. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.
Needham D; Anyarambhatla G; Kong G; Dewhirst MW
Cancer Res; 2000 Mar; 60(5):1197-201. PubMed ID: 10728674
[TBL] [Abstract][Full Text] [Related]
15. Antivascular and antitumor activities of liposome-associated drugs.
Straubinger RM; Arnold RD; Zhou R; Mazurchuk R; Slack JE
Anticancer Res; 2004; 24(2A):397-404. PubMed ID: 15152936
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer with bugs and liposomes: ready, aim, fire.
Cheong I; Huang X; Thornton K; Diaz LA; Zhou S
Cancer Res; 2007 Oct; 67(20):9605-8. PubMed ID: 17942887
[TBL] [Abstract][Full Text] [Related]
17. [Delivery in hypoxic tumor regions of a chemotherapeutic agent encapsulated in nanoliposomes carried by magnetoaerotactic bacteria].
Felfoul O; Mohammadi M; Taherkhani S; de Lanauze D; Zhong Xu Y; Lafleur M; Gaboury L; Tabrizian M; Vuong T; Batist G; Beauchemin N; Radzioch D; Martel S
Med Sci (Paris); 2018 Mar; 34(3):197-199. PubMed ID: 29547100
[No Abstract] [Full Text] [Related]
18. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
[TBL] [Abstract][Full Text] [Related]
19. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
Shenoy VS; Vijay IK; Murthy RS
J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery.
Leyland-Jones B
Semin Oncol; 1993 Feb; 20(1):12-7. PubMed ID: 8475405
[No Abstract] [Full Text] [Related]
[Next] [New Search]